In this context, the use of HMGA2 inhibitors, such as suramin, an antiparasitic drug used for the treatment of African sleeping sickness but also a potent inhibitor for HMGA2-DNA interactions [59], showing anti-cancer and anti-metastasis activities [60], is very promising. Here, HMGA2 is linked to human African trypanosomiasis.